IL-2/B7.1 fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: A strategy to generate whole cell vaccines for AML

IL-2/B7.1 fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: A strategy to generate whole cell vaccines for AML

Podrobná bibliografie
Hlavní autoři:	Chan, L, Hardwick, N, Darling, D, Galea-Lauri, J, Gaken, J, Devereux, S, Kemeny, M, Mufti, G, Farzaneh, F
Médium:	Journal article
Vydáno:	2004

Podobné jednotky

IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
Autor: Chan, L, a další
Vydáno: (2005)

Transduction of Primary AML Cells with Lentiviral Vector for In Vitro Study or In Vivo Engraftment
Autor: Aaron D. Schimmer, a další
Vydáno: (2020-12-01)

Fusagene vectors: A novel strategy for the expression of multiple genes from a single cistron
Autor: Gaken, J, a další
Vydáno: (1998)

Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron.
Autor: Gäken, J, a další
Vydáno: (2000)

Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron
Autor: Gaken, J, a další
Vydáno: (2001)

Tumour cells expressing B7.1 costimulatory molecule: Are these better targets for NK cells?
Autor: GaleaLauri, J, a další
Vydáno: (1996)

Induction of tumour rejection by autologous and allogeneic tumour cells expressing B7.1 and IL-2.
Autor: Hirst, W, a další
Vydáno: (1996)

Induction of tumour rejection by B7.1 and IL-2 expressing tumour cells
Autor: Gaken, J, a další
Vydáno: (1997)

Preclinical validation: LV/IL-12 transduction of patient leukemia cells for immunotherapy of AML
Autor: Ju Huang, a další
Vydáno: (2016-01-01)

TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
Autor: Eleonora De Bellis, a další
Vydáno: (2017-07-01)

Monocistronic high titre vectors for targeted expression of multiple therapeutic genes
Autor: Darling, D, a další
Vydáno: (2004)

High titre vectors for targeted expression of multiple genes
Autor: Darling, D, a další
Vydáno: (2004)

Comparative analysis of extracellular vesicle isolation methods from human AML bone marrow cells and AML cell lines
Autor: Jonas B. Lang, a další
Vydáno: (2022-10-01)

Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of established tumors.
Autor: Gaken, J, a další
Vydáno: (1997)

The Metabolic Signature of AML Cells Treated With Homoharringtonine
Autor: Yulong Zhang, a další
Vydáno: (2022-06-01)

MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML
Autor: Naidu M. Vegi, a další
Vydáno: (2016-07-01)

Automated and closed clinical-grade manufacturing protocol produces potent NK cells against neuroblastoma cells and AML blasts
Autor: Farhana Jahan, a další
Vydáno: (2024-11-01)

AML1/ETO oncoprotein is directed to AML1 binding regions and co-localizes with AML1 and HEB on its targets.
Autor: Alessandro Gardini, a další
Vydáno: (2008-11-01)

Prospects of immune gene therapy for cancer
Autor: Hardwick, N, a další
Vydáno: (2004)

MicroRNA-mRNA Pairs Associated with Outcome in AML: From in vitro Cell-based Studies to AML Patients
Autor: Neha S Bhise, a další
Vydáno: (2016-01-01)

Cytoplasmic NEAT1 Suppresses AML Stem Cell Self‐Renewal and Leukemogenesis through Inactivation of Wnt Signaling
Autor: Huiwen Yan, a další
Vydáno: (2021-11-01)

An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemia.
Autor: Chan, L, a další
Vydáno: (2006)

Abolishing Retro-Transduction of Producer Cells in Lentiviral Vector Manufacturing
Autor: Soledad Banos-Mateos, a další
Vydáno: (2024-07-01)

Identification of a small molecule for enhancing lentiviral transduction of T cells
Autor: Paulina Malach, a další
Vydáno: (2023-12-01)

Biomarkers as targets for CAR-T/NK cell therapy in AML
Autor: Ruonan Shao, a další
Vydáno: (2023-06-01)

Chimeric antigen receptor T-cell therapy for T-ALL and AML
Autor: Wenwen Wei, a další
Vydáno: (2022-11-01)

P577: 20% BLAST CRITERIA FOR DIAGNOSING AML/MDS: IS IT TIME TO MOVE BEYOND?
Autor: V. Sheth, a další
Vydáno: (2022-06-01)

Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients
Autor: Peter Holicek, a další
Vydáno: (2023-03-01)

8-Hydroxydaidzein Induces Apoptosis and Inhibits AML-Associated Gene Expression in U-937 Cells: Potential Phytochemical for AML Treatment
Autor: Pei-Shan Wu, a další
Vydáno: (2023-10-01)

Alteration of T cell immunity by lentiviral transduction of human monocyte-derived dendritic cells
Autor: Chang Lung-Ji, a další
Vydáno: (2004-11-01)

P1309: DYSREGULATED EXPRESSIONS OF INHIBITORY CHECKPOINT MOLECULES AND THEIR LIGANDS ON T-CELLS AND BLASTS IN AML RELAPSES AFTER STEM CELL TRANSPLANTATION (SCT)
Autor: S. Bohlscheid, a další
Vydáno: (2022-06-01)

P1350: M2-LIKE MONOCYTE-DERIVED MACROPHAGES PROTECT AML CELL LINES AND PRIMARY AML CELLS AGAINST THERAPY-INDUCED APOPTOSIS
Autor: Katerina Miari, a další
Vydáno: (2023-08-01)

THE CHALLENGE OF AML IN OLDER PATIENTS
Autor: Alan K Burnett
Vydáno: (2013-06-01)

The Evolving Treatment Landscape of AML
Autor: Sabine Blum, a další
Vydáno: (2022-03-01)

Maintenance of telomere length in AML
Autor: Peter M. Lansdorp
Vydáno: (2017-11-01)

Inherited predisposition to MDS/AML
Autor: Ana Rio Machin, a další
Vydáno: (2018-06-01)

The Evolving Treatment Landscape of AML
Autor: Sabine Blum, a další
Vydáno: (2022-03-01)

Emerging agents and regimens for AML
Autor: Hongtao Liu
Vydáno: (2021-03-01)

TARGETED THERAPY IN AML TREATMENT
Autor: Giovanni Martinelli
Vydáno: (2021-11-01)

ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AML.
Autor: Marta E Capala, a další
Vydáno: (2014-01-01)